LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...
Clopidogrel is prescribed to help prevent cardiovascular events such as heart attack and stroke in certain adults. It’s a generic medication that's available as the brand-name drug Plavix. The drug ...
New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix® ...
News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...
Sanofi’s annual results have revealed that generic rival Apotex paid it and partner Bristol-Myers Squibb over $445 million to settle a dispute over blockbuster drug Plavix The French pharmaceutical ...
NEW YORK, Jan 22 (Reuters) - A lawyer for Sanofi-Aventis and Bristol-Myers Squibb Co. urged a U.S. judge to uphold the patent on blockbuster anti-clotting medication Plavix on Monday, as a high-stakes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results